(RNR) Renaissancere Holdings - Ratings and Ratios
Reinsurance, Insurance, Property, Casualty, Specialty
EPS (Earnings per Share)
Revenue
Dividends
| Dividend Yield | 0.59% |
| Yield on Cost 5y | 1.00% |
| Yield CAGR 5y | 2.67% |
| Payout Consistency | 99.3% |
| Payout Ratio | 4.6% |
| Risk via 5d forecast | |
|---|---|
| Volatility | 26.8% |
| Value at Risk 5%th | 44.4% |
| Relative Tail Risk | 0.62% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 0.28 |
| Alpha | 0.05 |
| CAGR/Max DD | 0.55 |
| Character TTM | |
|---|---|
| Hurst Exponent | 0.427 |
| Beta | 0.371 |
| Beta Downside | 0.353 |
| Drawdowns 3y | |
|---|---|
| Max DD | 23.10% |
| Mean DD | 9.02% |
| Median DD | 8.44% |
Description: RNR Renaissancere Holdings January 04, 2026
RenaissanceRe Holdings Ltd. (NYSE:RNR) is a Bermuda-based reinsurance group that underwrites both property catastrophe excess-of-loss contracts and a broad suite of casualty-and-specialty products for insurers worldwide, distributing primarily through intermediaries.
Key operating metrics (as of FY 2023) include net written premiums of $13.2 billion, a combined ratio of 96.5 % in the Property segment, and a loss-adjusted capital ratio of 5.8 ×, reflecting strong underwriting discipline and capital strength.
Sector drivers that materially affect RNR’s outlook are: (1) the accelerating frequency and severity of climate-related catastrophes, which lift demand for excess-of-loss cover; (2) rising interest rates that enhance investment income but can pressure the pricing of long-dated liabilities; and (3) the cyclical nature of reinsurance pricing, where soft markets compress margins while hard markets expand them.
For a deeper quantitative view, you might explore ValueRay’s detailed risk-adjusted performance metrics for RNR.
Piotroski VR‑10 (Strict, 0-10) 6.0
| Net Income (1.73b TTM) > 0 and > 6% of Revenue (6% = 726.2m TTM) |
| FCFTA 0.07 (>2.0%) and ΔFCFTA -0.07pp (YES ≥ +1.0pp, WARN ≥ +0.5pp) |
| NWC/Revenue -153.1% (prev -48.52%; Δ -104.6pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp) |
| CFO/TA 0.07 (>3.0%) and CFO 3.99b > Net Income 1.73b (YES >=105%, WARN >=100%) |
| Net Debt (527.6m) to EBITDA (2.79b) ratio: 0.19 <= 3.0 (WARN <= 3.5) |
| Current Ratio 0.08 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active) |
| Outstanding Shares last Quarter (47.3m) change vs 12m ago -7.51% (target <= -2.0% for YES) |
| Gross Margin 27.49% (prev 41.33%; Δ -13.84pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0) |
| Asset Turnover 22.57% (prev 23.87%; Δ -1.30pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0) |
| Interest Coverage Ratio 24.67 (EBITDA TTM 2.79b / Interest Expense TTM 112.7m) >= 6 (WARN >= 3) |
Altman Z'' -0.98
| (A) -0.34 = (Total Current Assets 1.70b - Total Current Liabilities 20.23b) / Total Assets 54.50b |
| (B) 0.19 = Retained Earnings (Balance) 10.11b / Total Assets 54.50b |
| (C) 0.05 = EBIT TTM 2.78b / Avg Total Assets 53.63b |
| (D) 0.29 = Book Value of Equity 10.15b / Total Liabilities 35.53b |
| Total Rating: -0.98 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D) |
ValueRay F-Score (Strict, 0-100) 89.05
| 1. Piotroski 6.0pt |
| 2. FCF Yield 29.90% |
| 3. FCF Margin 32.96% |
| 4. Debt/Equity 0.19 |
| 5. Debt/Ebitda 0.19 |
| 6. ROIC - WACC (= 13.79)% |
| 7. RoE 16.03% |
| 8. Rev. Trend 84.57% |
| 9. EPS Trend 8.35% |
What is the price of RNR shares?
Over the past week, the price has changed by -4.11%, over one month by +3.04%, over three months by +2.25% and over the past year by +10.11%.
Is RNR a buy, sell or hold?
- Strong Buy: 2
- Buy: 4
- Hold: 4
- Sell: 1
- Strong Sell: 1
What are the forecasts/targets for the RNR price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 290.9 | 7% |
| Analysts Target Price | 290.9 | 7% |
| ValueRay Target Price | 301.5 | 10.8% |
RNR Fundamental Data Overview January 04, 2026
P/E Trailing = 7.6002
P/E Forward = 8.6281
P/S = 1.049
P/B = 1.2057
P/EG = -3.13
Beta = 0.264
Revenue TTM = 12.10b USD
EBIT TTM = 2.78b USD
EBITDA TTM = 2.79b USD
Long Term Debt = 2.23b USD (from longTermDebt, last quarter)
Short Term Debt = 449.8m USD (from shortTermDebt, last fiscal year)
Debt = 2.23b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 527.6m USD (from netDebt column, last quarter)
Enterprise Value = 13.34b USD (12.81b + Debt 2.23b - CCE 1.70b)
Interest Coverage Ratio = 24.67 (Ebit TTM 2.78b / Interest Expense TTM 112.7m)
FCF Yield = 29.90% (FCF TTM 3.99b / Enterprise Value 13.34b)
FCF Margin = 32.96% (FCF TTM 3.99b / Revenue TTM 12.10b)
Net Margin = 14.31% (Net Income TTM 1.73b / Revenue TTM 12.10b)
Gross Margin = 27.49% ((Revenue TTM 12.10b - Cost of Revenue TTM 8.78b) / Revenue TTM)
Gross Margin QoQ = 51.70% (prev 47.13%)
Tobins Q-Ratio = 0.24 (Enterprise Value 13.34b / Total Assets 54.50b)
Interest Expense / Debt = 1.37% (Interest Expense 30.6m / Debt 2.23b)
Taxrate = 10.05% (148.9m / 1.48b)
NOPAT = 2.50b (EBIT 2.78b * (1 - 10.05%))
Current Ratio = 0.08 (Total Current Assets 1.70b / Total Current Liabilities 20.23b)
Debt / Equity = 0.19 (Debt 2.23b / totalStockholderEquity, last quarter 11.50b)
Debt / EBITDA = 0.19 (Net Debt 527.6m / EBITDA 2.79b)
Debt / FCF = 0.13 (Net Debt 527.6m / FCF TTM 3.99b)
Total Stockholder Equity = 10.81b (last 4 quarters mean from totalStockholderEquity)
RoA = 3.18% (Net Income 1.73b / Total Assets 54.50b)
RoE = 16.03% (Net Income TTM 1.73b / Total Stockholder Equity 10.81b)
RoCE = 21.33% (EBIT 2.78b / Capital Employed (Equity 10.81b + L.T.Debt 2.23b))
RoIC = 20.26% (NOPAT 2.50b / Invested Capital 12.34b)
WACC = 6.47% (E(12.81b)/V(15.04b) * Re(7.38%) + D(2.23b)/V(15.04b) * Rd(1.37%) * (1-Tc(0.10)))
Discount Rate = 7.38% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 8.05%
Shares Correlation 3-Years: -100.0 | Cagr: -3.80%
[DCF Debug] Terminal Value 81.43% ; FCFE base≈3.95b ; Y1≈4.88b ; Y5≈8.32b
Fair Price DCF = 3069 (DCF Value 141.51b / Shares Outstanding 46.1m; 5y FCF grow 25.0% → 3.0% )
EPS Correlation: 8.35 | EPS CAGR: -7.61% | SUE: -2.20 | # QB: 0
Revenue Correlation: 84.57 | Revenue CAGR: 24.75% | SUE: 1.61 | # QB: 1
EPS next Quarter (2026-03-31): EPS=9.91 | Chg30d=+0.067 | Revisions Net=+2 | Analysts=3
EPS next Year (2026-12-31): EPS=34.00 | Chg30d=+0.193 | Revisions Net=+1 | Growth EPS=-28.4% | Growth Revenue=-0.3%
Additional Sources for RNR Stock
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle